Synthesis, NMR characterization and in vitro cytotoxicity evaluation of new poly(oxyethylene aminophosphonate)s

The synthesis of four novel poly(oxyethylene aminophosphonate)s through an addition of poly(oxyethylene H-phosphonate)s to N-(4-dimethylaminobenzylidene)-p-toluidine or N-furfurylidene-p-toluidine is reported. The IR and 1H, 13C and 31P NMR data of the poly(aminophosphonate)s are given. The polymers consist of aminophosphonate and poly(ethylene glycol) (PEG) units only. They are expected to act in vivo as prodrugs of the aminophosphonates and will be interesting as a new class of biodegradable polymer drug carriers. The cytotoxicity of the synthesized poly(aminophosphonate)s and two previously described analogues, was tested against a panel of human tumor cell lines, using cisplatin as reference cytotoxic agent. The presence of 2-furyl-p-toluidino moiety with a longer PEG (13 units) chain were identified as structural prerequisites affording superior activity, while the analogues originating from the Schiff bases N-(4-dimethylaminobenzylidene)-p-toluidine and N,N-dimethyl-N′-furfurylidene-1,3-diaminopropane were generally less active. In all sub-series of polymers the reduction of the PEG chain length from 13 to 4 units led to a significant reduction in relative potency. The established cytotoxicity, which in most of the polymers was comparable to that of cisplatin give us reason to consider the presented polymers as a novel class of aminophosphonate-based cytotoxic agents.

Graphical abstractNovel poly(oxyethylene aminophosphonate)s were synthesized and tested for cytotoxicity in vitro. The bio-assay revealed that the polymers represent a promising new class of aminophosphonate-based cytotoxic agents.Figure optionsDownload full-size imageDownload as PowerPoint slideResearch highlights► Synthesis of new poly(oxyethylene aminophosphonate)s ► Spectroscopic characterization (IR, 1H, 13C and 31P NMR) of poly(oxyethylene aminophosphonate)s ► In vitro cytotoxicity evaluation of the newly synthesized poly(oxyethylene aminophosphonate)s against a panel of human tumor cell lines.